{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T07:45:38Z","timestamp":1776671138759,"version":"3.51.2"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Egypt Heart J"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Gilbert syndrome is a human genetic disorder which affects bilirubin metabolism in the liver and results in unconjugated hyperbilirubinemia. While considered a benign condition with only occasional jaundice and possible alterations of metabolism of certain drugs, Gilbert syndrome can reduce cardiovascular disease (CVD) risk. The objective of this review was to summarize the evidence on the potential effect of Gilbert Syndrome on reducing CVD risk via lowering cholesterol and\/or lipid levels in the body and is associated with other protective mechanisms which are related to higher blood levels of unconjugated bilirubin.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A systematic review of articles returned from the online database PubMed was conducted using search terms: \u201cGilbert syndrome\u201d, \u201creduced cardiovascular disease risk\u201d, \u201ccardiovascular disease\u201d, \u201ccholesterol\u201d, and \u201clipid level\u201d.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>After filtering using the exclusion criteria and removing duplicates, eight articles were identified for the review. This review found that CVD risk was lower for people with Gilbert syndrome when compared to unaffected individuals. The reduced CVD risk was theorized to be due to elevated unconjugated bilirubin levels which lead to reduced concentrations of lipids, reduced inflammation biomarkers, decreased ABCA1 protein, increased serum antioxidant capacity expression, decreased BMI, and lower triglyceride levels.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Individuals with Gilbert syndrome have a reduced CVD risk. Given that Gilbert syndrome reduces CVD risk in individuals and that Gilbert syndrome results in elevated serum levels of unconjugated bilirubin; elevation of unconjugated bilirubin could serve as a biomarker to monitor CVD risk reduction in the general population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s43044-026-00738-3","type":"journal-article","created":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T06:53:25Z","timestamp":1776668005000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effects of Gilbert syndrome on cardiovascular disease risk reduction: a systematic review"],"prefix":"10.1186","volume":"78","author":[{"given":"Nicola","family":"Churchill","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luke","family":"Barry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roch","family":"Nianogo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,20]]},"reference":[{"key":"738_CR1","doi-asserted-by":"publisher","first-page":"2203380","DOI":"10.1002\/ADHM.202203380","volume":"12","author":"N Guirguis","year":"2023","unstructured":"Guirguis N, Bertrand AX, Rose CF, Matoori S (2023) 175 Years of Bilirubin Testing: Ready for Point-of\u2010Care? Adv Healthc Mater 12:2203380. https:\/\/doi.org\/10.1002\/ADHM.202203380","journal-title":"Adv Healthc Mater"},{"key":"738_CR2","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.3390\/ANTIOX14111326","volume":"14","author":"ZA Kipp","year":"2025","unstructured":"Kipp ZA, Pauss SN, Martinez GJ, Hinds TD, Lee WH (2025) Bilirubin Hepatic and Intestinal Transport and Catabolism: Physiology, Pathophysiology, and Benefits. Antioxidants 14:1326. https:\/\/doi.org\/10.3390\/ANTIOX14111326","journal-title":"Antioxidants"},{"key":"738_CR3","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/S0022-2275(20)38539-4","volume":"29","author":"JD Ostmw","year":"1988","unstructured":"Ostmw JD, Celic L, Mukerjeet P (1988) Molecular and micellar associations in the pH-dependent stable and metastable dissolution of unconjugated bilirubin by bile salts. J Lipid Res 29:335\u2013348. https:\/\/doi.org\/10.1016\/S0022-2275(20)38539-4","journal-title":"J Lipid Res"},{"key":"738_CR4","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1161\/hypertensionaha.118.11130","volume":"72","author":"TD Hinds Jr","year":"2018","unstructured":"Hinds TD Jr, Stec DE (2018) Bilirubin, a Cardiometabolic Signaling Molecule. Hypertension 72:788\u2013795. https:\/\/doi.org\/10.1161\/hypertensionaha.118.11130","journal-title":"Hypertension"},{"key":"738_CR5","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/S0168-8278(00)80268-8","volume":"33","author":"MTM Raijmakers","year":"2000","unstructured":"Raijmakers MTM, Jansen PLM, Steegers EAP, Peters WHM (2000) Association of human liver bilirubin UDP-glucuronyltransferase activity with a polymorphism in the promoter region of the UGT1A1 gene. J Hepatol 33:348\u2013351. https:\/\/doi.org\/10.1016\/S0168-8278(00)80268-8","journal-title":"J Hepatol"},{"key":"738_CR6","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/0016-5085(84)90705-4","volume":"87","author":"M Muraca","year":"1984","unstructured":"Muraca M, Fevery J (1984) Influence of sex and sex steroids on bilirubin uridine diphosphate-glucuronosyltransferase activity of rat liver. Gastroenterology 87:308\u2013313. https:\/\/doi.org\/10.1016\/0016-5085(84)90705-4","journal-title":"Gastroenterology"},{"key":"738_CR7","unstructured":"Chandrasekar VT, Faust TW, John S (2023) Gilbert Syndrome. StatPearls Publishing: Treasure Island (FL);"},{"key":"738_CR8","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/J.PLIPRES.2012.11.001","volume":"52","author":"AC Bulmer","year":"2013","unstructured":"Bulmer AC, Verkade HJ, Wagner KH (2013) Bilirubin and beyond: A review of lipid status in Gilbert\u2019s syndrome and its relevance to cardiovascular disease protection. Prog Lipid Res 52:193\u2013205. https:\/\/doi.org\/10.1016\/J.PLIPRES.2012.11.001","journal-title":"Prog Lipid Res"},{"key":"738_CR9","doi-asserted-by":"publisher","unstructured":"Jung E, Kong SY, Ro YS, Ryu HH, Shin S, Do (2022) Serum Cholesterol Levels and Risk of Cardiovascular Death: A Systematic Review and a Dose-Response Meta-Analysis of Prospective Cohort Studies. Int J Environ Res Public Health 19. https:\/\/doi.org\/10.3390\/IJERPH19148272","DOI":"10.3390\/IJERPH19148272"},{"key":"738_CR10","doi-asserted-by":"publisher","first-page":"e93","DOI":"10.1161\/cir.0000000000001123","volume":"147","author":"CW Tsao","year":"2023","unstructured":"Tsao CW, Aday AW, Almarzooq ZI et al (2023) Heart Disease and Stroke Statistics-2023 Update: A Report From the American Heart Association. Circulation 147:e93\u2013621. https:\/\/doi.org\/10.1161\/cir.0000000000001123","journal-title":"Circulation"},{"key":"738_CR11","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1016\/j.freeradbiomed.2012.03.002","volume":"52","author":"AC Boon","year":"2012","unstructured":"Boon AC, Hawkins CL, Bisht K, Coombes JS, Bakrania B, Wagner KH, Bulmer AC (2012) Reduced circulating oxidized LDL is associated with hypocholesterolemia and enhanced thiol status in Gilbert syndrome. Free Radic Biol Med 52:2120\u20132127. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2012.03.002","journal-title":"Free Radic Biol Med"},{"key":"738_CR12","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1080\/09537104.2017.1280146","volume":"28","author":"AR Kundur","year":"2017","unstructured":"Kundur AR, Santhakumar AB, Bulmer AC, Singh I (2017) Mildly elevated unconjugated bilirubin is associated with reduced platelet activation-related thrombogenesis and inflammation in Gilbert\u2019s syndrome. Platelets 28:779\u2013785. https:\/\/doi.org\/10.1080\/09537104.2017.1280146","journal-title":"Platelets"},{"key":"738_CR13","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1146\/annurev-psych-010418","volume":"70","author":"AP Siddaway","year":"2019","unstructured":"Siddaway AP, Wood AM, Hedges LV (2019) How to Do a Systematic Review: A Best Practice Guide for Conducting and Reporting Narrative Reviews, Meta-Analyses, and Meta-Syntheses. Annu Rev Psychol 70:747\u2013770. https:\/\/doi.org\/10.1146\/annurev-psych-010418","journal-title":"Annu Rev Psychol"},{"key":"738_CR14","doi-asserted-by":"publisher","first-page":"d2293","DOI":"10.1136\/bmj.d2293","volume":"342","author":"LC Claridge","year":"2011","unstructured":"Claridge LC, Armstrong MJ, Booth C, Gill PS (2011) Gilbert\u2019s syndrome. BMJ 342:d2293. https:\/\/doi.org\/10.1136\/bmj.d2293","journal-title":"BMJ"},{"key":"738_CR15","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.clinbiochem.2010.12.003","volume":"44","author":"S Tapan","year":"2011","unstructured":"Tapan S, Karadurmus N, Dogru T et al (2011) Decreased small dense LDL levels in Gilbert\u2019s syndrome. Clin Biochem 44:300\u2013303. https:\/\/doi.org\/10.1016\/j.clinbiochem.2010.12.003","journal-title":"Clin Biochem"},{"key":"738_CR16","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1042\/cs20120661","volume":"125","author":"M Wallner","year":"2013","unstructured":"Wallner M, Marculescu R, Doberer D et al (2013) Protection from age-related increase in lipid biomarkers and inflammation contributes to cardiovascular protection in Gilbert\u2019s syndrome. Clin Sci (Lond) 125:257\u2013264. https:\/\/doi.org\/10.1042\/cs20120661","journal-title":"Clin Sci (Lond)"},{"key":"738_CR17","doi-asserted-by":"publisher","unstructured":"Wang D, Tosevska A, Hei\u00df EH et al (2017) Bilirubin Decreases Macrophage Cholesterol Efflux and ATP-Binding Cassette Transporter A1 Protein Expression. J Am Heart Assoc 6. https:\/\/doi.org\/10.1161\/jaha.117.005520","DOI":"10.1161\/jaha.117.005520"},{"key":"738_CR18","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/s0021-9150(01)00601-3","volume":"160","author":"L V\u00edtek","year":"2002","unstructured":"V\u00edtek L, Jirsa M, Brodanov\u00e1 M et al (2002) Gilbert syndrome and ischemic heart disease: a protective effect of elevated bilirubin levels. Atherosclerosis 160:449\u2013456. https:\/\/doi.org\/10.1016\/s0021-9150(01)00601-3","journal-title":"Atherosclerosis"},{"key":"738_CR19","first-page":"360","volume":"32","author":"I O\u010dadl\u00edk","year":"2011","unstructured":"O\u010dadl\u00edk I, Hlin\u0161t\u00e1kov\u00e1 S, Oravec S (2011) Relationship between unconjugated hyperbilirubinemia and lipoprotein spectrum. Neuro Endocrinol Lett 32:360\u2013364","journal-title":"Neuro Endocrinol Lett"},{"key":"738_CR20","doi-asserted-by":"publisher","unstructured":"Kundur AR, Singh I, Bulmer AC (2015) Bilirubin, platelet activation and heart disease: a missing link to cardiovascular protection in Gilbert\u2019s syndrome? Atherosclerosis. 239:73\u201384. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2014.12.042","DOI":"10.1016\/j.atherosclerosis.2014.12.042"},{"key":"738_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12967-021-03207-4","volume":"20","author":"G Wen","year":"2022","unstructured":"Wen G, Yao L, Hao Y, Wang J, Liu J (2022) Bilirubin ameliorates murine atherosclerosis through inhibiting cholesterol synthesis and reshaping the immune system. J Transl Med 20:1. https:\/\/doi.org\/10.1186\/s12967-021-03207-4","journal-title":"J Transl Med"}],"container-title":["The Egyptian Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43044-026-00738-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s43044-026-00738-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43044-026-00738-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T06:53:27Z","timestamp":1776668007000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s43044-026-00738-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,20]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["738"],"URL":"https:\/\/doi.org\/10.1186\/s43044-026-00738-3","relation":{},"ISSN":["2090-911X"],"issn-type":[{"value":"2090-911X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,20]]},"assertion":[{"value":"14 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"25"}}